-
marketed under the
brands CellCept (mycophenolate
mofetil by Roche) and
Myfortic (mycophenolate
sodium by Novartis).
Cellcept was
developed by a South...
-
derivative which was
eventually approved as an
immunosuppressive drug
called CellCept. He
contributed more than 400
technical papers and
edited 12 books. Allison...
-
facility to
Lonza and
acquired an
exclusive right to
purchase Lonza's
mammalian cell culture manufacturing facility under construction in Singapore. In June 2007...
- by
autoantibodies targeting aquaporin 4 (AQP4), a
channel protein in the
cell membrane that
allows water to p****
through the membrane. AQP4
monomers form...
-
response measured in
magnetoencephalography Mycophenolate mofetil (tradename
CellCept), an
immunosuppressant drug used to
prevent rejection in
organ transplantation...
-
injection of steroids, such as
dexamethasone Immunosuppressant drugs, such as
CellCept (mycophenolic acid): In
recent years,
adjuvant drugs,
especially biologics...
- Rosenthal, Don; Dutz, Jan; Ho,
Vincent (July 1, 2003). "Mycophenolate
Mofetil (
CellCept) for Psoriasis: A Two-Center, Prospective, Open-Label
Clinical Trial"....
- 09.006. ISSN 1568-9972. "FDA Alert:
Mycophenolate Mofetil (marketed as
CellCept) and
Mycophenolic Acid (marketed as Myfortic)". U.S. Food and Drug Administration...
- immunoglobulin,
immunosuppressive agents like rituximab,
mycophenolate mofetil (
Cellcept), or
azathioprine (Imuran) or plasmapheresis. The
ganglionic AChR antibody...
- [citation needed]
Second line
therapies include:
mycophenolate mofetil (
cellcept)
which inactivates inosine monophosphate, most
studied in
clinical trials...
